Foqus PGCL USP 0 Triangular Needle

Foqus PGCL USP 0 Triangular Needle is a high precision disposable surgical instrument, specifically designed to ensure reliability and safety in numerous medical and surgical interventions, both in hospital and outpatient settings. It is a sterile thread equipped with a triangular needle, ideal for suturing soft tissues. The structure of the polyglecaprone (PGCL) thread allows for excellent handling, excellent tensile strength during the suturing phase and a predictable and reliable absorption profile, promoting safe tissue healing. The combination of the latest generation thread and the acutely sharp triangular needle facilitates clean penetration into the tissues, reducing local trauma and ensuring stable anchoring of the flaps in a homogeneous and controlled way.

This device is particularly appreciated for its versatility, finding use in general surgery, plastic and reconstructive surgery, gynecology, pediatric surgery, urology and in all those disciplines where rapid reabsorbability of the suture and high compatibility with different types of tissue are required. The triangular needle guarantees superior precision when passing through fabrics, avoiding fraying or sagging of the thread and favoring the best possible aesthetic result thanks to its pointed shape on three sides. The special treatment of the needle surface reduces friction during tissue penetration, minimizing pain and the risk of post-operative complications.

Therapeutic Indications

The use of Foqus PGCL USP 0 Triangular Needle is recommended in the surgical closure of soft tissues where a temporary suture is required that guarantees resistance in the first days of the healing process, followed by gradual reabsorption without the need for manual removal. The product finds wide application in the suturing of surgical wounds, skin incisions, traumatic lacerations, aesthetic and reconstructive plastics, in the skin flaps of grafts and transplants, in abdominal, gynecological, obstetric and pediatric surgery and in the suturing of subcutaneous tissues. Its particular composition also makes it suitable for pediatric patients or subjects with a predisposition to skin reactions, reducing the possibility of adverse reactions during the healing phase.

They are also suitable for use in urological procedures and in the sutures of medium-sized blood vessels, benefiting from the haemostatic function of the suture. Thanks to its gradual and predictable resorption, the Foqus PGCL USP 0 Triangular Needle can be used in procedures where it is desired to avoid suture removal or where removal would be difficult or painful for the patient. In situations such as deep wounds, the triangular needle facilitates penetration without causing incidental damage to surrounding tissues, improving patient comfort and healing time.

Composition

Active ingredient: The surgical thread is made of poliglecaprone (PGCL), a completely absorbable monofilament synthetic polymer. Its monofilament structure ensures smoothness in the tissues and reduces bacterial colonization on the surface of the thread, improving the safety of the surgical site. The needle is made of high quality medical grade stainless steel with a sharp triangular section to aid tissue penetration and smoothness. The needle is sharpened on three sides to allow precise and clean penetration.

Excipients: There are no added coloring or allergenic agents. The material complies with international standards of purity and biocompatibility, for a rapid favorable histological response and prevention of infections. The entire needle-thread system is sterilized by gamma irradiation, guaranteeing perfect sterility of the device upon use. The components are latex-free, minimizing the risk of allergies.

Contraindications

The Foqus PGCL USP 0 Triangular Needle is contraindicated in patients with proven hypersensitivity to poliglecaprone or to metals used in the needle such as stainless steel. Do not use the device for suturing cardiovascular or neurological tissue, or for microsuturing tissue that requires long-term durable support, as the resorbable nature of the thread does not offer sustained support beyond the physiological resorption period. It is contraindicated in untreated infected environments, as early dissolution may compromise the tightness of the suture. Also not recommended in patients with reduced healing capacity or in the presence of autoimmune diseases affecting the skin and soft tissues, in the risk of possible reopening of the wound due to early degradation of the suture material.

Safety of the drug for the species

The Foqus PGCL USP 0 Triangular Needle was designed to ensure maximum safety of use in human tissues, thanks to the in-depth study of the mechanical and biological properties of the thread and needle. It does not interfere with normal healing processes and generates a minimal local inflammatory response. The risk of infections related to the use of this product is extremely reduced thanks to the monofilament structure of the PGCL which does not retain bacteria and the sterilization guaranteed in each package. The material decomposes homogeneously within the organism, avoiding accumulations and localized granulation phenomena. Clinical studies highlight an excellent tolerability profile, both in adults and children, even in patients with a predisposition to skin sensitivity.

Thanks to its design, the triangular needle minimizes tissue breakage and reduces the risk of tears and micro-lesions during suturing. The complete absence of latex in the packaging and materials guarantees safety even for allergic subjects. No negative interactions have been recorded with other sterile medical devices or local drugs applied concomitantly to the sutured wound.

Precautions

Use Foqus PGCL USP 0 Triangular Needle only by adequately trained medical personnel, following the normal asepsis and antisepsis procedures required in the operating room or clinic. It is important to check the integrity of the sterile packaging before use. Do not use if the blister is damaged or open. During the suturing phase, avoid overloading the thread beyond the declared resistance to avoid possible breakage or premature failure.

Pay particular attention in immunosuppressed, diabetic or healing-deficient patients, regularly monitoring the progress of the wound. Avoid using the device for suturing tissue under prolonged tension. In case of local adverse reactions, such as redness, persistent pain or signs of infection, consult your healthcare professional promptly. Dispose of the needle according to hospital safety procedures for sharps waste. Wash your hands and materials used thoroughly after the procedure.

Method of administration

For best results, suturing with the Foqus PGCL USP 0 Triangular Needle should be performed using standard aseptic suturing techniques. After identifying the edges of the fabrics to be joined, the triangular needle is delicately introduced by making a perpendicular penetration, making sure that the direction of the cut follows the tension lines of the fabric. Given the remarkable sharpness of the triangular needle, the passage through the tissues occurs with minimal effort, allowing excellent handling and determining a clean and precise closure.

The thread must be pulled gently, avoiding excessive stretching. After tying with the appropriate surgical knots, cut the excess thread leaving sufficient length to encourage natural decomposition, without the need for subsequent removal. Keep the area clean and monitor the tightness and appearance of the suture following normal post-surgery protocols.

Treatment program

The residence time of the Foqus PGCL USP 0 Triangular Needle in the tissues varies according to the thickness and type of operation performed, but is, in general, between approximately 10 and 30 days, with a progressive loss of tensile strength that accompanies the normal course of the healing process. In general or specialized interventions where a temporary seal is required, the programming of the suture must be in line with the physiological timing of resorption, evaluating the risk of stress or prolonged traction on the suture.

It is good practice to periodically monitor the sutured area, especially in the first days after surgery to check the integrity of the thread and the absence of signs of infection or failure. No removal operation is required, as the material is gradually and completely reabsorbed, without residue. In case of sutures on areas subject to greater movement, consider the possibility of using temporary protective bandages.

Target species

The device is intended exclusively for use on human soft tissue in the context of surgical, outpatient or emergency procedures where temporary, fully absorbable suture support is required. Do not use in hard tissue, bone or in veterinary areas.